Clinical Trials Bristol-Myers Squibb invests more than $3.5 billion each year to discover and develop innovative medicines to help patients prevail against serious diseases.

In the past several years, we have delivered a number of new products for patients in need, including medicines for psychiatric disorders, rheumatoid arthritis, hepatitis B, cancer, HIV/AIDS and diabetes. In addition, our pipeline continues to expand. In all, there are more than 60 investigational compounds in 10 diseases areas, listed below. About one-third of our compounds in development are biologics.

  • Alzheimer’s disease
  • Cancer
  • Diabetes
  • Heart disease
  • Hepatitis
  • HIV/AIDS
  • Obesity
  • Organ transplant rejection
  • Psychiatric disorders
  • Rheumatoid arthritis

In the true spirit of science, we are dedicated to educating and sharing our clinical trials information and data with patients, medical/research communities, the media, policy makers and the general public. We act on our belief that the priceless ingredient of every product is the integrity of its maker.

Clinical Trial Registry

Find information on all new or existing Bristol-Myers Squibb-sponsored clinical trials.

Clinical Trial Results

Data on Bristol-Myers Squibb's marketed products from clinical trials conducted around the world.